Rethinking Intelligence Quotient Exclusion Criteria Practices in the Study of Attention Deficit Hyperactivity Disorder

被引:23
作者
Mackenzie, Genevieve B. [1 ]
Wonders, Elif [2 ]
机构
[1] Univ Toronto, Ontario Inst Studies Educ, Attent Deficit Hyperact Disorder & Literacy Lab, Toronto, ON, Canada
[2] McGill Univ, Dept Educ & Counselling Psychol, Connect Lab, Montreal, PQ, Canada
来源
FRONTIERS IN PSYCHOLOGY | 2016年 / 7卷
关键词
attention deficit/hyperactivity disorder; intelligence quotient; exclusion criteria; inclusion criteria; mild intellectual impairment; SLUGGISH COGNITIVE TEMPO; DEFICIT/HYPERACTIVITY DISORDER; CHILDREN; ADHD; IQ; ATOMOXETINE; ADOLESCENTS; INHIBITION; ADULTS; METHYLPHENIDATE;
D O I
10.3389/fpsyg.2016.00794
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Attention deficit hyperactivity disorder (ADHD) is associated with lower than average intelligence quotient (IQ) scores. However, research done on this disorder often excludes participants based on lower than average IQ's (i.e., between 70 and 85). The purpose of this paper is to alert researchers to the consequences of excluding participants based on IQ's within this range and to highlight the importance of providing a clear rationale when choosing to exclude participants based on IQ. Next, we offer recommendations for researching ADHD and their relative benefits and drawbacks of these approaches. Overall this paper emphasizes that including participants who have lower than average IQ in research on ADHD may promote a more realistic understanding of the condition and in turn improve our ability to treat it.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Inattentiveness in attention-deficit/hyperactivity disorder
    Sroubek, Ariane
    Kelly, Mary
    Li, Xiaobo
    NEUROSCIENCE BULLETIN, 2013, 29 (01) : 103 - 110
  • [32] Treatment Approaches to Attention Deficit Hyperactivity Disorder
    Antai-Otong, Deborah
    Zimmerman, Michele L.
    NURSING CLINICS OF NORTH AMERICA, 2016, 51 (02) : 199 - +
  • [33] Attention-Deficit-Hyperactivity Disorder: An Update
    Dopheide, Julie A.
    Pliszka, Steven R.
    PHARMACOTHERAPY, 2009, 29 (06): : 656 - 679
  • [34] Attention deficit hyperactivity disorder and epilepsy in childhood
    Angeles Idiazabal-Alecha, M.
    Kosno, Magdalena
    REVISTA DE NEUROLOGIA, 2012, 54 : S89 - S93
  • [35] Genetic Variability in Attention Deficit Hyperactivity Disorder
    Kuzelova, H.
    Macek, M., Jr.
    Raboch, J.
    Ptacek, R.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2014, 77 (04) : 423 - 427
  • [36] The neurobiology of attention-deficit/hyperactivity disorder
    Chamberlain, Samuel R.
    Robbins, Trevor W.
    Sahakian, Barbara J.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (12) : 1317 - 1319
  • [37] Neuroimaging in Attention-Deficit/Hyperactivity Disorder: Recent Advances
    Firouzabadi, Fatemeh Dehghani
    Ramezanpour, Sara
    Firouzabadi, Mohammad Dehghani
    Yousem, Ilyssa J.
    Puts, Nicolaas A. J.
    Yousem, David M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (02) : 321 - 332
  • [38] Effects of Methylphenidate and Atomoxetine Treatment on Improvement of Motor Coordination in Children With Attention-Deficit/Hyperactivity Disorder
    Kim, Ju Yeon
    Jung, Eunji
    Lee, Taeyeop
    Park, Kee Jeong
    Joung, Yoo-Sook
    Kim, Hyo-Won
    PSYCHIATRY INVESTIGATION, 2025, 22 (01) : 84 - 92
  • [39] Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder
    Vaughan, Brigette
    Fegert, Joerg
    Kratochvil, Christopher J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (04) : 669 - 676
  • [40] Attention deficit and hyperactivity disorder disrupts selective mechanisms of action
    Coubard, Olivier A.
    CLINICAL NEUROPHYSIOLOGY, 2022, 140 : 145 - 158